No filter, high-puff frequency, higher quantities of nicotine and tar in bidi The Tribune, now published from Chandigarh, ...

focusing on key genes linked to non-small cell lung cancer (NSCLC). Advt The study found that adenocarcinoma was the most ...

Mumbai, Maharashtra, India Lung cancer remains one of the most prevalent and deadly cancers globally, with approximately 2.2 ...

Penpulimab in combination therapy for the first-line treatment of metastatic NPC, has had its marketing application accepted by the NMPA and the FDA. Additionally, the marketing application for its ...

A chemotherapy-free regimen of neoadjuvant nivolumab (Opdivo) with or without ipilimumab (Yervoy) induced immune activation ...

Genprex has entered an exclusive licensing agreement with the University of Michigan for lung cancer therapy, Reqorsa.

Pyxis Oncology shares dropped 40% after phase 1 data on PYX-201 for solid tumors, as one participant death raises concern.

Louisiana residents have one of the highest lung cancer death rates in the country, even as groundbreaking treatments in ...

Calidi Biotherapeutics, Inc. recently disclosed information revealing the latest advancements in its targeted antitumor virotherapies. The company’s press release, titled “Calidi Biotherapeutics ...

Alpha DaRT® accepted into the prestigious Total Product Life Cycle Advisory Program (TAP) of the FDA, to accelerate market access to the Alpha ...

Cutaneous Squamous Cell Carcinoma KEYTRUDA is indicated for the ... chemotherapy for the first-line treatment of adult patients with metastatic non-small cell lung cancer (NSCLC). The Phase 3 trial ...

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.